UK markets open in 5 hours 27 minutes

Hyloris Pharmaceuticals SA (HYL.BR)

Brussels - Brussels Delayed price. Currency in EUR
Add to watchlist
11.700.00 (0.00%)
At close: 05:37PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-12,462
-10,770
-11,579
-7,145
Depreciation & amortisation
267
196
114
581
Stock-based compensation
599
560
576
485
Change in working capital
919
-3,375
-776
31
Other working capital
-11,645
-13,893
-12,311
-5,193
Other non-cash items
-269
695
197
1,477
Net cash provided by operating activities
-10,882
-13,154
-11,250
-4,570
Cash flows from investing activities
Investments in property, plant and equipment
-763
-739
-1,061
-623
Acquisitions, net
-
-
-1,270
0
Purchases of investments
22
-500
-1,178
-10
Sales/maturities of investments
-
-
216
0
Other investing activities
-
-
-1
-
Net cash used for investing activities
-593
-1,239
-3,075
-633
Net change in cash
-18,527
-6,555
-14,387
64,194
Cash at beginning of period
57,687
50,012
64,399
205
Cash at end of period
39,160
43,457
50,012
64,399
Free cash flow
Operating cash flow
-10,882
-13,154
-11,250
-4,570
Capital expenditure
-763
-739
-1,061
-623
Free cash flow
-11,645
-13,893
-12,311
-5,193